Research ArticleDrug Discovery and Translational Medicine
The triple angiokinase inhibitor nintedanib directly inhibits tumor cell growth and induces tumor shrinkage via blocking oncogenic receptor tyrosine kinases
Frank Hilberg, Ulrike Tontsch-Grunt, Anke Baum, Anh T Le, Robert C Doebele, Simone Lieb, Davide Dianni, Tilman Voss, Pilar Garin-Chesa, Christian Haslinger and Norbert Kraut
Journal of Pharmacology and Experimental Therapeutics December 20, 2017, jpet.117.244129; DOI: https://doi.org/10.1124/jpet.117.244129
